Abstract
THIS REPORT:
Provides a thorough evaluation of the market for influenza vaccines,
therapeutics, and diagnostics Offers a global analysis, with emphasis on U.S.
data, and a five-year forecast period through 2014 Identifies markets in the
segments of vaccines/therapeutics and diagnostics. Each market segment
discussion provides detailed information based on product categories, use of
products, forecasts, and competitive analysis Covers some of the most
significant issues, trends and market factors Profiles the top companies and
major players in the market.
INTRODUCTION
STUDY GOALS AND OBJECTIVES
This BCC Research report, The Global Influenza Market: Vaccines, Therapeutics,
and Diagnostics is an update to the BCC Research report published in 2006
titled, The Worldwide Influenza Market (PHM049A). This report provides an
overview of products currently in the marketplace and a detailed analysis of
market position and competitive environments. The study includes information
about products available, products in development, issues and trends
influencing the market, and competitive analysis of top providers. There is a
special emphasis on U.S. and European markets.
REASONS FOR DOING THE STUDY
Annually, up to a half - million people die of influenza and, with the threat
of a pandemic, government agencies and disease prevention organizations are
devoted to gaining control of the situation. Many companies have been asked to
assist with the problem and others are furthering their position with backing
from government agencies. The next 5 years will continue to display support
and funding for many research and development programs, product development
and pandemic prevention and/or control by worldwide governments,
organizations, and health professionals.
SCOPE OF REPORT
This BCC Research report is designed to be a helpful business tool that
provides a thorough evaluation of the market for influenza vaccines,
therapeutics, and diagnostics. The geographic scope of this study is
worldwide, with emphasis on U.S. data. The report identifies markets in
general segments: Vaccines/Therapeutics and Diagnostics. Each market segment
discussion provides detailed information based on product categories, uses of
products, forecasts, and competitive analyses. Additionally, the study covers
some of the most significant issues and trends and market factors.
METHODOLOGY
The information for this BCC report was obtained through primary and secondary
data collection methods. Primary methods included interviews with key
representatives in the industry: product development managers, clinical
specialists, government departments, and other key representatives involved in
the influenza industry. Secondary methods included published literature,
investment reports, company literature, and various business journals that
have emphasis on influenza products, technology and related information.
Market data for this report pertains to the worldwide market, with specific
U.S. data included. All information is displayed using U.S. dollars at the
manufacturers' level. The base year of the report is 2009, with historical
data provided for 2007 and 2008, and forecast data provided through 2014.
Historical, base year, and forecast data are provided for each market segment
of the report. Compound annual growth rates are determined through a
compilation of data, including past trends, future trends, demographics,
incidence, mortality, products in research and development, current product
growth, and government intervention and stockpiling trends. Competitor market
share estimates are provided for each market segment for the 2009 base year.
| 
View Cart
